This site is initiated and funded by Recordati Rare Diseases. This website is intended for members of the public in the UK and Ireland.

Our Medicines
The information supplied on this page is intended for members of the public.
Our Medicines
The information supplied on this page is intended for members of the public.
Below, you can find links to reference information regarding our products.
Please note that this information is specific to the UK & Ireland and is not intended to replace the advice of your healthcare team.
Product Name
|
Active Ingredient
|
UK Summary of Product Characteristics
|
UK Patient Information Leaflet
|
Ireland Summary of Product Characteristics & Package Leaflet
|
---|---|---|---|---|
Carbaglu
|
carglumic acid
|
|||
Cosmegen Lyovac
|
dactinomycin
|
Not available
|
||
Cystadane
|
betaine anhydrous
|
|||
Cystadrops
|
mercaptamine hydrochloride
|
|||
Cystagon
|
mercaptamine bitartrate
|
|||
Enjaymo▼
|
sutimlimab
|
Not available
|
Not available
|
|
Fotivda
|
tivozanib hydrochloride monohydrate
|
|||
*Isturisa▼
|
osilodrostat phosphate
|
|||
Ledaga
|
chlormethine hydrochloride
|
|||
Normosang
|
human hemin
|
Not available
|
||
Pedea
|
ibuprofen
|
|||
Qarziba▼
|
dinutuximab beta
|
|||
Signifor
|
pasireotide diaspartate
|
|||
Signifor
|
pasireotide pamoate
|
|||
Sylvant▼
|
siltuximab
|
|||
Vedrop▼
|
tocofersolan
|
|||
Wilzin
|
zinc acetate dihydrate
|
*Isturisa is not subject to additional monitoring in Ireland.
If you're a patient (or a carer)
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk for how to report side effects.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
UK: You can also report side effects directly to the MHRA via the Yellow Card Scheme at: https://yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of this medicine.
Ireland: You can also report side effects directly to the HPRA at using the Adverse Reaction Form or by calling the HPRA on +353-1-6764971.
Side-effects can also be reported to Recordati Rare Diseases by telephone: +44 (0) 1491 414 333 or email: .